Seleziona una pagina

PARADIGM SHIFTS IN GYNECOLOGIC ONCOLOGY

Learning with friends

PARADIGM SHIFTS IN GYNECOLOGIC ONCOLOGY

THE RATIONALE 

 

Over the last years, some publications in the oncologic field dramatically impacted the management of gynecological cancers. In this context, we wanted to organize an event to share the results of the most significant studies, which somehow represented a paradigm shift in uterine, cervical, and ovarian cancers. 

The primary objective of this one-day conference is to give a chance to the attendances to understand the meaning of working in teams and learning from mentors and friends. High-level national and international speakers will share their expertise and provide inspiring talks with unique insights.

The proposed topics will be presented with reference to evidence-based medicine, national and international guidelines. The interactive sessions will give the opportunity to question leading experts and be inspired by best practices from other countries. The conference arguments will be of great interest not only to gynecologic oncologists but also to pathologists, general gynecologists, nurses, and physicians in training.

Negli ultimi anni diverse pubblicazioni scientifiche di rilievo hanno avuto un impatto drastico sulle metodiche di diagnosi e trattamento delle maggiori neoplasie ginecologiche. Abbiamo voluto organizzare un evento per condividere i risultati degli studi più significativi, che in qualche modo hanno rappresentato un cambiamento “paradigmatico” nell’approccio del tumore dell’utero, della cervice e dell’ovaio.

L’obiettivo primario di questa conferenza è quello di dare la possibilità ai partecipanti di comprendere il significato di lavorare in team e imparare da mentori e professionisti di riferimento assoluto. In un clima di amicizia, speakers di livello internazionale condivideranno le loro competenze ed esperienze professionali, con interventi motivazionali e intuizioni uniche.

Gli argomenti proposti saranno presentati con riferimento alle più recenti evidenze scientifiche e alle ultime linee guida nazionali ed internazionali. Le sessioni interattive daranno l’opportunità di interagire con gli esperti ed essere ispirati dalle migliori pratiche cliniche di diversi paesi. Gli argomenti della conferenza saranno di grande interesse non solo per ginecologi-oncologi, ma anche per ginecologi generali, anatomopatologi, infermieri e medici in formazione.

 

PRELIMINARY PROGRAM

 

One day together to examine in depth all the aspects of gynecologic oncology in a climate of friendship and thirst for knowledge

FRIDAY, NOVEMBER 13

08.15- Registration
08.45- Opening session – J. Casarin
09.00- Gynecologic Oncology at “Del Ponte Hospital” of Varese: past present and future perspectives- F. Ghezzi

Session 1. UTERINE MALIGNANCIES

Chair: F. Ghezzi / S. Greggi /V. Zanagnolo
09.30- Minimally invasive surgery in endometrial cancer: the long and winding road to reduce morbidity –S. Cappuccio
09.50- Lymphadenectomy vs. sentinel lymph node biopsy: surgical and oncological outcomes – N. Abu-Rustum
10.10- The “5Ws”of adjuvant treatment in endometrial cancer: What – When – Where – to Whom and Why? – A. Mariani
10.30- Sarcoma, or not sarcoma. That is the question – F. Multinu
10.45- Molecular genetics in endometrial cancer: what’s the clinical implication? – T. Grassi
11.00- Discussion on uterine malignancies- S. Cappuccio, N. Abu-Rustum, A. Mariani, F. Multinu, T. Grassi.

11.20- Coffee break

Session 2. CERVICAL CANCER

Chair: F. Raspagliesi / A. Gadducci / M. Franchi
11.40- The Role of Human Papillomavirus Vaccines in Cervical Cancer: Prevention and Treatment – G. Bogani
12.00- Surgical treatment for apparent early stage cervical cancer: back to the “open” forever? P. Ramirez
12.20- Contraindication to NACT and surgery in locally advanced cervical cancer – F. Landoni
12.40- Pelvic exenteration for cervical cancer recurrences: is there still a role? A. Maggioni
13.00- Discussion on cervical cancer- G. Bogani, P. Ramirez, F. Landoni, A. Maggioni.

13.20- Lunch

14.00- Friendship in science and medicine – N. Abu-Rustum – A. Mariani – P. Ramirez
14.30- Leadership in gynecology – O. Famuyide

Session 3. OVARIAN CANCER

Chair: G. Scambia – P. Scollo
15.00- Early detection in ovarian cancer – A. Ahmed
15.20- Advanced utrasound evaluation: impact on the preoperative work-up for in early stage and advanced ovarian cancer – D. Sturla
15.40- Improving the outcome of early ovarian cancer treatment – S. Uccella
16.00- Radical surgery in ovarian cancer: morbidity and oncological outcomes – G. Aletti
16.20- Neoadjuvant chemotherapy for advanced stage ovarian cancer: how to select the patients? –L. Tortorella
16.40- PARP Inhibitor to improve PFS in ovarian cancer patients – D. Lorusso
17.00- Discussion on ovarian cancer- A. Ahmed, D. Sturla, S. Uccella, G. Aletti, L. Tortorella, D. Lorusso.
17.20- Fill in the main mandatory forms and final test

FABIO GHEZZI

FABIO GHEZZI

President

JVAN CASARIN

JVAN CASARIN

Scientific Chair

SERENA CAPPUCCIO

SERENA CAPPUCCIO

Scientific Committee

FRANCESCO MULTINU

FRANCESCO MULTINU

Scientific Committee

 

FACULTY

NADEEM R. ABU-RUSTUM, NEW YORK, NY USA
AHMED A. AHMED, OXFORD, UK
GIOVANNI ALETTI MILAN, ITALY
GIORGIO BOGANI, MILAN, ITALY
SERENA CAPPUCCIO, ROME, ITALY
JVAN CASARIN, VARESE, ITALY
MASSIMO FRANCHI, VERONA, ITALY
ANGIOLO GADDUCCI, PISA, ITALY
FABIO GHEZZI, VARESE, ITALY
TOMMASO GRASSI, MONZA, ITALY
STEFANO GREGGI, NAPLES, ITALY

FABIO LANDONI, MONZA, ITALY
DOMENICA LORUSSO, ROME, ITALY
ANGELO MAGGIONI, MILAN, ITALY
ANDREA MARIANI, ROCHESTER, MN, USA
FRANCESCO MULTINU, MILAN, ITALY
PEDRO RAMIREZ, HOUSTON, TX, USA
FRANCESCO RASPAGLIESI, MILAN, ITALY
GIOVANNI SCAMBIA, ROME, ITALY
DAVIDE STURLA, VARESE, ITALY
LUCIA TORTORELLA, ROME, ITALY
STEFANO UCCELLA, VERONA, ITALY
VANNA ZANAGNOLO, MILANO, ITALY

INFORMATION

ECM (CONTINUED MEDICAL EDUCATION)

The congress has been inserted on the formative schedule 2020 of PSA & CF SRL ( NATIONAL PROVIDER ECM STANDARD N. 210) for the assignment of the ECM:

PROVIDER ECM: PSA & CF SRL

ID. PROVIDER: N. 210

TITLE: PARADIGM SHIFTS IN GYNECOLOGIC ONCOLOGY

DATE: 13th OF NOVEMBER 2020

LOCATION: VILLE PONTI – VARESE

EVENT NUMBER:

EDITION: 1

NUMBER OF PARTICIPANTS: MAX 150

FORMATIVE HOURS: 7

FORMATIVE CREDITS: 5.25

PROFESSION FOR WHICH CREDITS WILL BE REQUESTED:

– SURGICAL DOCTORS

 

 

 

LOCATION

Ville Ponti

Piazza Litta, 2, 21100 Varese VA

HOW TO REACH US

FROM THE HIGHWAY / DALL'AUTOSTRADA

You can reach us from the other cities taking the highway A8 and exit at Varese city center and then following the directions for ‘Parco di Villa Panza’.

Per raggiungerci dalle altre città è possibile utilizzare l’autostrada A8 prendendo l’uscita per Varese centro città, per poi seguire le direzioni per “Parco di Villa Panza”.

FROM THE AIRPORT / DALL'AEROPORTO

You can get to Varese from different airports (Malpensa, Linate, Bergamo) by taking the highway or by train and taking a cab. (around 10 euros)

Varese è raggiungibile da diversi aeroporti (Malpensa, Linate, Bergamo) prendendo l’autostrada o il treno ed infine un taxi (il costo del taxi è di circa 10 €)

FROM THE RAILWAY STATION / DALLE STAZIONI

From the stations (Varese Nord and Varese FS) it would be possible to take a cab. (around 10 euros)

Dalle stazioni (Varese nord e Varese FS) sarà possibile prendere un taxi per raggiungere la location (il costo del taxi di circa 10 €) 

SPONSORS INFORMATIONS

FIRST FLOOR

SPOTS AVAILABLE

SPOTS UNAVAILABLE

Register now!

An important event that you won’t miss.
Reports, presentations, insights into topics …

 
Via Bernardo Bellotto 6 | 21100 Varese | 0332 –1570554 | informazioni@psacf.it | psacf@pec.it | Partita IVA: 03124950126

Contact us

Privacy

13 + 4 =

PSA & CF Eventi